Citicoline Sodium 500 mg tablets

Citicoline Sodium 500 mg Tablets (CAS 987-78-0)

Citicoline Sodium (CDP-Choline; CAS 987-78-0) is a pharmaceutically active compound supporting cognitive health and neuronal membrane synthesis. In B2B contexts, 500 mg tablet forms are leveraged in nootropic drug development, geriatric formulations, post-stroke neurorehabilitation programs, and cognitive function enhancement therapies. Citicoline enhances acetylcholine levels and supports phospholipid metabolism in the brain, making it valuable across CNS, neurology, and psychiatry portfolios.

These tablets offer ready-to-scale formulations for companies in clinical trials, hospital tenders, and third-party manufacturing of memory support or attention-enhancing products.

What are the synonyms of Citicoline Sodium used in global sourcing and documentation?

• CDP-Choline Sodium
• Cytidine-5′-diphosphocholine sodium salt
• Citicoline monosodium salt
• Sodium citicoline
• Choline cytidine diphosphate sodium

How can Citicoline Sodium 500 mg Tablets support contract manufacturing and neuropharma R&D?

Pharmaceutical and nutraceutical companies utilize citicoline sodium in multiple B2B pathways:

• CDMO Engagement: Used in custom solid-dosage development for brain health portfolios.
• Preclinical & Clinical Trials: Supplied as a reference product or active comparator in neuroprotection studies.
• R&D Formulation: Citicoline serves as a proven scaffold for developing combination nootropics or geriatric care regimens.
• Neuroscience Research: Offers consistent pharmacokinetics ideal for mechanistic studies targeting choline and cytidine pathways.
• Institutional Programs: Governments and NGOs use citicoline tablets in cognitive decline management for aging populations.

These use-cases highlight its growing demand in regulated and semi-regulated markets, especially where neurodegenerative disorders are rising.

What are the technical and regulatory specifications of Citicoline Sodium 500 mg tablets for bulk buyers?

• API: Citicoline Sodium (CDP-Choline), 500 mg/tablet
• Form: Film-coated, oral solid tablet
• Molecular Formula: C₁₄H₂₇N₄NaO₁₁P₂
• Molecular Weight: 510.3 g/mol
• Packaging: Blister strips or HDPE bulk jars per client specification
• Shelf Life: 24–36 months under controlled storage
• Labeling: Custom/private-label options available upon request
• Export Classification: Non-scheduled; requires end-use declaration in select countries
• Stability Zone Data: Available for ICH Zones II–IV
• Quality Benchmarks: Follows Ph. Eur./USP monographs where applicable

Why choose Pharmint as your bulk supplier for Citicoline Sodium tablets?

Pharmint provides a compliance-first, globally oriented procurement model built for scalability:

• GMP-Grade Assurance: Manufactured under strict GMP with traceable production logs and ISO-certified processes.
• Full Documentation Set: Each batch includes Certificate of Analysis (COA), Safety Data Sheet (MSDS), and optional DMF access.
• Flexible MOQ & Logistics: We accommodate MOQ requests from 10K tablets upwards and support sea/air freight with cold-chain options.
• Regulatory Navigation: Assistance with end-use declarations, controlled-substance assessment, and country-specific documentation.
• Quality Consistency: Robust stability and dissolution data ensures replicability across development and commercialization stages.
• Dedicated B2B Support: Clients receive sourcing intelligence, repeat batch matching, and territory-specific regulatory guidance.

Who should procure Citicoline Sodium tablets for B2B formulation or research use?

• Generic drug manufacturers seeking neuroprotective agents
• Private-label wellness brands expanding into brain health
• Academic research labs studying neuroplasticity or choline metabolism
• CDMOs/CRAMs looking to develop CNS-centric product lines
• Public health agencies running aging-related or cognitive support programs
• Hospitals & Neuro Clinics sourcing evidence-backed neuro supplements

Pharmint enables streamlined purchasing with technical transparency, long-term supply forecasting, and responsive QA support for pharmaceutical-grade materials.

Citicoline Sodium Tablets FAQs

Can citicoline sodium tablets be co-formulated with other neuro APIs?

Yes, citicoline sodium allows co-formulation with racetams, L-theanine, or B-vitamins, supporting synergistic neurocognitive pathways in dual-action nootropic blends or CNS support therapies.

Does citicoline sodium meet global pharmacopoeial standards?

Citicoline sodium complies with USP and Ph. Eur. identity and purity benchmarks, making it suitable for regulated pharmaceutical development and international dossier submissions.

What documentation is needed for citicoline sodium tablet import/export?

Pharmint provides COA, MSDS, and batch-level specifications, and supports buyers with end-use declarations or regulatory clearance depending on destination country requirements.

Is citicoline sodium classified as a controlled substance in any region?

Citicoline sodium is not listed as a controlled substance under most jurisdictions but may be restricted in dosage form imports or require declaration for neuroactive APIs.

How does citicoline sodium compare to choline bitartrate in formulations?

Citicoline sodium offers higher bioavailability, dual choline-cytidine support, and enhanced CNS penetration compared to choline bitartrate, making it preferable for neurotherapeutics.